INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,669 Cr | ₹1,541 Cr | ₹1,242 Cr | ₹1,107 Cr | ₹968 Cr |
What is the latest Revenue of INDOCO REMEDIES ?
Year | Revenue |
---|---|
Mar2024 | ₹1,669 Cr |
Mar2023 | ₹1,541 Cr |
Mar2022 | ₹1,242 Cr |
Mar2021 | ₹1,107 Cr |
Mar2020 | ₹968 Cr |
How is Revenue of INDOCO REMEDIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,669 Cr | 8.30 | |
Mar2023 | ₹1,541 Cr | 24.10 | |
Mar2022 | ₹1,242 Cr | 12.19 | |
Mar2021 | ₹1,107 Cr | 14.26 | |
Mar2020 | ₹968 Cr | - |
Compare Revenue of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,920.0 Cr | 0.1% | 7.5% | 0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 0.1% |
7.5% |
0.1% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses